Knowledge graph-based approaches to drug repurposing for COVID-19

The COVID-19 pandemic has motivated researchers across the globe to find effective drugs and therapeutics for treating the disease. Many efforts have focused on repurposing existing drugs used for other illnesses to save time. The CAS Biomedical Knowledge Graph was developed to identify drugs that can be repurposed to treat COVID-19.

This peer-reviewed article published in the Journal of Chemical Information and Modeling examines this graph and its results in greater detail. It shows how various molecules were analyzed according to molecular function and clinical trials. This graph not only provides an opportunity to accelerate innovation and research for COVID-19 but many other diseases as well. Read the full publication here.

Read the full journal publication

Related CAS Insights

創薬

A review of the global efforts on COVID-19 vaccine development

March 29, 2021

Read article
創薬

ACE2という、疾病病因特定において潜在的に重要なレセプターを標的にする

December 15, 2022

Read article
創薬

ACS webinar on molecular glues and targeted protein degradation

October 12, 2022

Read article

Gain new perspectives for faster progress directly to your inbox.